FR2358421B1 - - Google Patents

Info

Publication number
FR2358421B1
FR2358421B1 FR7721933A FR7721933A FR2358421B1 FR 2358421 B1 FR2358421 B1 FR 2358421B1 FR 7721933 A FR7721933 A FR 7721933A FR 7721933 A FR7721933 A FR 7721933A FR 2358421 B1 FR2358421 B1 FR 2358421B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7721933A
Other languages
French (fr)
Other versions
FR2358421A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of FR2358421A1 publication Critical patent/FR2358421A1/fr
Application granted granted Critical
Publication of FR2358421B1 publication Critical patent/FR2358421B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0023—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16
    • C07J5/003—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes
    • C07J5/0038—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group including 16-alkylidene substitutes by an alkyl group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR7721933A 1976-07-16 1977-07-18 Corticosteroides et medicaments qui en contiennent Granted FR2358421A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2632678A DE2632678C2 (de) 1976-07-16 1976-07-16 6α-Fluor-12α-Halogen-Kortikoide und Verfahren zu ihrer Herstellung

Publications (2)

Publication Number Publication Date
FR2358421A1 FR2358421A1 (fr) 1978-02-10
FR2358421B1 true FR2358421B1 (enExample) 1979-05-11

Family

ID=5983515

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7721933A Granted FR2358421A1 (fr) 1976-07-16 1977-07-18 Corticosteroides et medicaments qui en contiennent

Country Status (11)

Country Link
JP (1) JPS5315361A (enExample)
AT (1) AT355743B (enExample)
BE (1) BE856862A (enExample)
CH (1) CH627191A5 (enExample)
DE (1) DE2632678C2 (enExample)
DK (1) DK323877A (enExample)
FR (1) FR2358421A1 (enExample)
GB (1) GB1589585A (enExample)
IT (1) IT1125789B (enExample)
LU (1) LU77768A1 (enExample)
NL (1) NL7707920A (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2244000B (en) * 1990-05-18 1993-09-22 Teasdale S Mattress
MX2012010824A (es) 2010-03-26 2012-10-10 Galderma Res & Dev Metodos y composiciones mejoradas para tratamiento seguro y efectivo del eritema.
EP2768502A2 (en) 2011-10-19 2014-08-27 Galderma S.A. Method of reducing facial flushing associated with systemic use of phosphodiesterase type 5 inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3053837A (en) * 1958-10-01 1962-09-11 Olin Mathieson 16, 17-acetal and ketal derivatives of 6alpha, 12alpha-dihalo-16alpha, 17alpha-dihydroxy steroids of the pregnane series; and intermediates therefor
GB1179547A (en) * 1965-12-22 1970-01-28 Squibb & Sons Inc 01beta,12beta-Oxido-16alpha-Methyl-Pregnenes

Also Published As

Publication number Publication date
ATA504777A (de) 1979-08-15
DE2632678A1 (de) 1978-01-26
GB1589585A (en) 1981-05-13
LU77768A1 (enExample) 1977-10-17
NL7707920A (nl) 1978-01-18
FR2358421A1 (fr) 1978-02-10
JPS5315361A (en) 1978-02-13
BE856862A (fr) 1978-01-16
DK323877A (da) 1978-01-17
AT355743B (de) 1980-03-25
CH627191A5 (en) 1981-12-31
IT1125789B (it) 1986-05-14
DE2632678C2 (de) 1986-02-27

Similar Documents

Publication Publication Date Title
JPS548683B2 (enExample)
DK141212C (enExample)
JPS5619759B2 (enExample)
DK137832C (enExample)
DK467977A (enExample)
JPS559119Y2 (enExample)
DK142306C (enExample)
FR2358421B1 (enExample)
JPS5552416Y2 (enExample)
JPS563452Y2 (enExample)
JPS5345973U (enExample)
JPS5631959Y2 (enExample)
FR2372776B1 (enExample)
JPS5311065U (enExample)
JPS5642308Y2 (enExample)
FR2340787B1 (enExample)
JPS5528166B2 (enExample)
JPS5379643U (enExample)
JPS52131794U (enExample)
JPS52116305U (enExample)
JPS52104515U (enExample)
JPS52103032U (enExample)
JPS52144423U (enExample)
JPS5311225U (enExample)
DK577876A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse